Differences in Manufacturer Reporting of Adverse Drug Reactions to the FDA in 1984
- 1 July 1987
- journal article
- research article
- Published by Springer Nature in Drug Information Journal
- Vol. 21 (3) , 257-266
- https://doi.org/10.1177/009286158702100302
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Adverse-Drug-Reaction MonitoringNew England Journal of Medicine, 1986
- Factors Affecting Physician Reporting of Adverse Drug ReactionsDrug Information Journal, 1986
- Postmarketing Reporting of Adverse Drug Reactions to the FDA: An Overview of the 1985 FDA GuidelineDrug Information Journal, 1986
- Postmarketing Surveillance of New Drugs: I. Review of Objectives and MethodologyThe Journal of Clinical Pharmacology, 1979
- Factors Determining Physician Reporting of Adverse Drug ReactionsNew England Journal of Medicine, 1969